3-methoxybenzamide has been researched along with Staphylococcal Infections in 3 studies
*Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiwale, ST; Baker, PJ; Barynin, VV; Bennett, JM; Brown, DR; Chauhan, PK; Collins, I; Czaplewski, LG; Errington, J; Galbraith, G; Haydon, DJ; Heal, JR; Rice, DW; Sedelnikova, SE; Sheridan, JM; Srivastava, A; Stokes, NR; Taneja, A; Ure, R | 1 |
| Beanland, J; Bennett, JM; Brown, D; Chauhan, PK; Collins, I; Czaplewski, L; Galbraith, G; Hall, R; Haydon, DJ; Henstock, V; Lancett, P; Macdonald, R; Nayal, N; Noula, C; Rockley, C; Srivastava, A; Stokes, NR; Sutariya, JK | 1 |
| Baker, N; Bennett, JM; Berry, J; Collins, I; Czaplewski, LG; Haydon, DJ; Logan, A; Macdonald, R; Macleod, L; Mitchell, JP; Nayal, N; Peasley, H; Srivastava, A; Stokes, NR; Yadav, A | 1 |
3 other study(ies) available for 3-methoxybenzamide and Staphylococcal Infections
| Article | Year |
|---|---|
An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Binding Sites; Cell Division; Crystallography, X-Ray; Cytoskeletal Proteins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ligands; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Tubulin | 2008 |
Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceutical properties.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biological Availability; Blood Proteins; Caco-2 Cells; Cell Division; Cell Membrane Permeability; Cytoskeletal Proteins; Hepatocytes; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2010 |
An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Biological Availability; Colony Count, Microbial; Cytokinesis; Cytoskeletal Proteins; Drug Resistance, Multiple, Bacterial; Female; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Mutation; Oxazoles; Prodrugs; Staphylococcal Infections; Staphylococcus epidermidis; Succinates; Succinic Acid; Thigh; Treatment Outcome | 2013 |